Business Description
Corline Biomedical AB
ISIN : SE0006887451
Compare
Compare
Traded in other countries / regions
CLBIO.Sweden IPO Date
2015-06-03Description
Corline Biomedical AB is involved in developing, manufacturing and marketing heparin-based solutions to improve kidney transplantation, cell therapies, and applications in the field of regenerative medicine.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.91 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 16.18 | |||||
| Beneish M-Score | -3.04 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 157.8 | |||||
| 3-Year FCF Growth Rate | 13.6 | |||||
| 3-Year Book Growth Rate | 8.4 | |||||
| Future 3-5Y Total Revenue Growth Rate | 86.76 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.85 | |||||
| 9-Day RSI | 59.6 | |||||
| 14-Day RSI | 60.38 | |||||
| 6-1 Month Momentum % | -24.91 | |||||
| 12-1 Month Momentum % | -23.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.42 | |||||
| Quick Ratio | 2.42 | |||||
| Cash Ratio | 1.83 | |||||
| Days Sales Outstanding | 90.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.8 | |||||
| Shareholder Yield % | -0.19 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 116.22 | |||||
| Operating Margin % | -25.61 | |||||
| Net Margin % | -25.76 | |||||
| FCF Margin % | -19.28 | |||||
| ROE % | -4.16 | |||||
| ROA % | -3.84 | |||||
| ROIC % | -4.8 | |||||
| ROC (Joel Greenblatt) % | -1142.44 | |||||
| ROCE % | -4.13 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 17.84 | |||||
| PB Ratio | 2.95 | |||||
| Price-to-Tangible-Book | 20 | |||||
| Price-to-Operating-Cash-Flow | 65.08 | |||||
| EV-to-EBIT | -66.56 | |||||
| EV-to-Forward-EBIT | -85.31 | |||||
| EV-to-EBITDA | -67.82 | |||||
| EV-to-Forward-EBITDA | -85.31 | |||||
| EV-to-Revenue | 17.04 | |||||
| EV-to-Forward-Revenue | 5.56 | |||||
| EV-to-FCF | -90.52 | |||||
| Price-to-Net-Current-Asset-Value | 20.32 | |||||
| Price-to-Net-Cash | 34.59 | |||||
| Earnings Yield (Greenblatt) % | -1.5 | |||||
| FCF Yield % | -1.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Corline Biomedical AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 15.126 | ||
| EPS (TTM) (kr) | -0.18 | ||
| Beta | 0 | ||
| Volatility % | 42.45 | ||
| 14-Day RSI | 60.38 | ||
| 14-Day ATR (kr) | 0.728497 | ||
| 20-Day SMA (kr) | 12.1575 | ||
| 12-1 Month Momentum % | -23.88 | ||
| 52-Week Range (kr) | 9.64 - 18.15 | ||
| Shares Outstanding (Mil) | 21.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Corline Biomedical AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Corline Biomedical AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Corline Biomedical AB Frequently Asked Questions
What is Corline Biomedical AB(OSTO:CLBIO)'s stock price today?
The current price of OSTO:CLBIO is kr12.80. The 52 week high of OSTO:CLBIO is kr18.15 and 52 week low is kr9.64.
When is next earnings date of Corline Biomedical AB(OSTO:CLBIO)?
The next earnings date of Corline Biomedical AB(OSTO:CLBIO) is 2024-08-23.
Does Corline Biomedical AB(OSTO:CLBIO) pay dividends? If so, how much?
Corline Biomedical AB(OSTO:CLBIO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers